The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics is a clinical research site located in New York, New York, United States 10029.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Fragile X Syndrome.
Sponsors: Zynerba Pharmaceuticals, Inc..
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics has 3 clinical trials on record, with 1 currently active. Their work covers Fragile X Syndrome.
The Fragile X Spectrum Disorder Clinic at Icahn School of Medicine at Mount Sinai, Division of Medical Genetics has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.